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Poultry is the most frequent reservoir of non-typhoid Salmonella enterica for humans. Understanding the interactions
between chickens and S. enterica is therefore important for vaccine design and subsequent decrease in the incidence
of human salmonellosis. In this study we therefore characterized the interactions between chickens and phoP, aroA,
SPI1 and SPI2 mutants of S. Enteritidis. First we tested the response of HD11 chicken macrophage-like cell line to S.
Enteritidis infection monitoring the transcription of 36 genes related to immune response. All the mutants and the wild
type strain induced inflammatory signaling in the HD11 cell line though the response to SPI1 mutant infection was
different from the rest of the mutants. When newly hatched chickens were inoculated, the phoP as well as the SPI1
mutant did not induce an expression of any of the tested genes in the cecum. Despite this, such chickens were
protected against challenge with wild-type S. Enteritidis. On the other hand, inoculation of chickens with the aroA or
SPI2 mutant induced expression of 27 and 18 genes, respectively, including genes encoding immunoglobulins.
Challenge of chickens inoculated with these two mutants resulted in repeated induction of 11 and 13 tested genes,
respectively, including the genes encoding immunoglobulins. In conclusion, SPI1 and phoP mutants induced protective
immunity without inducing an inflammatory response and antibody production. Inoculation of chickens with the SPI2
and aroA mutants also led to protective immunity but was associated with inflammation and antibody production. The
differences in interaction between the mutants and chicken host can be used for a more detailed understanding of
the chicken immune system.Introduction
Non-typhoid Salmonella enterica serovars are among
the most common causative agents of food-borne dis-
eases worldwide [1]. Since poultry is the most frequent
reservoir of salmonellosis for humans, vaccination of
chickens is understood as an effective measure to
decrease S. enterica incidence in humans. Currently,
construction of attenuated vaccine strains of S. enterica
is not an issue and many different mutants have been
tested in mice, chickens and even humans [2-7]. How-
ever, the main dilemma is which mode of attenuation to
choose out of the many possibilities [8]. More detailed
information on host response to S. enterica infection or
vaccination is therefore needed. Such information can be
obtained either by generating chickens with knocked out* Correspondence: rychlik@vri.cz
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or by preparing S. enterica mutants with clearly defined
defects in pathogenesis and analysis of chicken immune
response. Since the former possibility is still an issue in
chickens, the latter approach represents a feasible
alternative.
Mutants with clearly different defects in Salmonella
pathogenesis include those with deletions in aroA, phoP,
SPI1 or SPI2. Reduced virulence of aroA mutants can be
explained by their inability to produce aromatic com-
pounds as well as having a high sensitivity to serum
[2,9]. phoP mutants belong to the most attenuated ones
as they fail to survive inside phagocytic cells [10], per-
haps due to their high sensitivity to acidification and
host antimicrobial peptides [11]. However, phoP mutants
also exhibit intracellular overgrowth in fibroblasts [12].
Recently, mutants defective in virulence genes specific toss This article is distributed under the terms of the Creative Commons
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
um, provided you give appropriate credit to the original author(s) and the
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ted.
Table 1 Salmonella Enteritidis strains used in the study
Strain Resistance1 Reference
S. Enteritidis 147 Nal [6]
S. Enteritidis 147 ΔSPI1 Nal [6]
S. Enteritidis 147 ΔSPI2 Nal [6]
S. Enteritidis 147 ΔaroA::Cm Nal, Cm [9]
S. Enteritidis 147 ΔphoP::Cm Cm [46]
1Nal, nalidixic acid; Cm, chloramphenicol.
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pathogenicity island (SPI) 1 and SPI2 have been success-
fully tested [5,13]. SPI1 mutants are impaired in invading
non-professional phagocytes while SPI2 mutants are
unable to survive intracellularly for a prolonged time
[14-17]. SPI1 mutants are also defective in induction of
apoptosis in macrophages [18,19]. Interestingly, when
we recently used SPI1 and SPI2 mutants of S. enterica
serovar Enteritidis for vaccination of chickens, higher
antibody levels were observed in chickens vaccinated
with the SPI2 mutant than in chickens vaccinated with
the SPI1 mutant [13]. Inactivation of different branches
of S. enterica virulence may therefore lead to its different
recognition by the chicken immune system and induc-
tion of a different type of specific immunity.
Comparison of chicken response to inoculation with
different S. enterica mutants is further complicated by
the fact that with increasing age, chickens become quite
resistant to S. enterica infection [20]. Consequently, al-
though there are numerically lower counts of Salmonella
in the liver and spleen, and lower inflammatory re-
sponses are recorded in 6-week-old vaccinated chickens
in comparison with non-vaccinated controls after chal-
lenge, such differences do not always reach statistical
significance with the numbers of chickens commonly
used under laboratory conditions. This was the reason
why we recently initiated research activities using gen-
omic and proteomic tools which led to the identification
of tens of genes whose expressions change after S. Enter-
itidis infection of newly hatched chickens [21,22]. Some
of them can be induced by S. Enteritidis infection even
in 42-day-old chickens [21], although our subsequent
study indicated that induction of these genes in 42-day-
old chickens might not be as reliable as we initially ex-
pected [23]. In this study we therefore first characterized
the response of chicken macrophage cell line HD11 to
infection with wild-type S. Enteritidis and aroA, phoP,
SPI1 and SPI2 mutants, as macrophages are considered
to play a key role in the immune response to Salmonella
infection. In the second part of this study we performed
in vivo experiments and compared the type of immunity
induced by oral inoculation of newly hatched chickens
with wild-type S. Enteritidis and its mutants. We found
out that the SPI1 or phoP mutants stimulated protective
immunity without inducing inflammation and immuno-
globulin production in vivo in the chicken cecum. aroA
or SPI2 mutants also induced protective immunity, how-
ever, inoculation of chickens with these mutants resulted
in moderate inflammation and antibody production.
Materials and methods
Bacterial strains and in vitro testing in HD11 cells
S. Enteritidis 147 spontaneously resistant to nalidixic
acid with a proven virulence in chickens and mice [6,24]was used in this study. All isogenic mutants had been
constructed earlier and are listed in Table 1. Chicken
macrophage-like cell line HD11 was cultured at 37 °C
under 5% CO2 atmosphere in RPMI-1640 (Sigma). Bac-
teria were grown statically in LB broth at 37 °C for 18 h.
This culture was diluted 800× in LB broth and incubated
for an additional 3 h at 37 °C to obtain bacteria in the
late logarithmic growth-phase of a highly invasive
phenotype. Prior to infection of HD11, the bacteria were
pelleted by centrifugation (10 min at 6500 × g) and re-
suspended in PBS to OD = 0.3. HD11 cells were infected
with S. Enteritidis or its mutants at a multiplicity of
infection equal to 1 for 1 h. Free bacteria were then
washed away and gentamicin was added to fresh RPMI-
1640 medium (100 μg/mL) to kill any remaining extra-
cellular bacteria. One hour later, the medium was
replaced with fresh medium containing 15 μg/mL
gentamicin to prevent multiplication of extracellular
bacteria that were eventually released during culture
from dead cells. Two and 22 h later, i.e. 4 and 24 h after
the infection of HD11 cells, the appropriate number of
wells were either lysed with 1% Triton X-100 to release
intracellular bacteria or treated with TRI Reagent for
RNA purification (see below). Serial decimal dilutions
were plated on LB agar plates to count released bacteria.
The whole experiment was performed in duplicates on
two independent occasions.
In vivo experimental design and sample collection
Male ISA Brown chickens (Hendrix Genetics, the
Netherlands) were obtained from a local commercial
hatchery on day of hatch. Chickens were reared in perfo-
rated plastic boxes with free access to water and feed.
Each experimental or control group was kept in a separate
room.
In the first experiment, 4 newly hatched chickens per
group were orally inoculated with 0.1 mL of wild-type
S. Enteritidis 147 and SPI1, SPI2, aroA or phoP mutants.
Infectious dose was approx. 108 CFU and infected chickens
were euthanized 4 days post infection (dpi). The control
group consisted of 4 non-infected chickens euthanized on
day 5 of life. During necropsy, approx. 30 mg of the cecum
was collected from each chicken, placed into RNALater
(Qiagen) and kept at −70 °C prior to RNA isolation.
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infected on day of hatch (day 1), on day 22 or day 43 of
life with approx. 108 CFU of S. Enteritidis 147. Infected
chickens were euthanized 4 dpi. Four age-matched non-
infected control chickens were also included. During
necropsy, cecum samples were collected into RNALater
and kept at −70 °C.
In the third experiment, 6 chickens per group were or-
ally inoculated with wild-type S. Enteritidis 147 and SPI1,
SPI2, aroA or phoP mutants on day 1 of life, orally chal-
lenged with 108 CFU of the wild-type S. Enteritidis on day
22, and euthanized 4 days later. Six age-matched, non-
infected control chickens and 6 non-inoculated but chal-
lenged chickens were also included in this experiment.
In the last experiment we verified results from the first
and third experiment. Sixteen chickens per group were
orally inoculated with wild-type S. Enteritidis 147 and
SPI1, SPI2, aroA or phoP mutants on day 1 of life. Six
chickens from each group were euthanized 4 days post
inoculation, another six chickens from each group were
euthanized prior to challenge on day 22 of life. The
remaining chickens were challenged on day 22 of life
and euthanized 4 days post challenge. Non-infected con-
trol chickens sacrificed on day 5 and 26 of life (4 chickens
per each time point), and 4 non-inoculated chickens
challenged on day 22 of life and sacrificed 4 days later
were included as well. Since the same experimental set up
was used in the experiments 1, 3 and 4, data from these
are combined in all figures or tables as appropriate.
All animal treatment and handling was performed in
accordance with the current Czech legislation (Animal
protection and welfare Act No. 246/1992 Coll. of the
Government of the Czech Republic) and has been
approved by the Ethics Committee for Animal Welfare
of the Ministry of Agriculture of the Czech Republic
(permit number MZe 1226).
Bacteriology
Approx. 0.5 g of liver tissue and cecal content was col-
lected from chickens during necropsy performed after
all experiments. The samples were homogenized in pep-
tone water, tenfold serially diluted and plated on XLD
agar plates (HiMedia) supplemented with nalidixic acid,
or Brilliant Green Agar (Oxoid) supplemented with
chloramphenicol in the case of the phoP mutant. Detec-
tion limit of direct plating was 500 CFU/g of sample.
Samples negative after direct plating were subjected to
enrichment in modified semi-solid Rappaport-Vassiliadis
medium (Oxoid) for qualitative S. Enteritidis counts
determination. Counts of S. Enteritidis found positive
after direct plating were logarithmically transformed.
Samples found positive only after enrichment were
assigned a value of 1 and negative samples were assigned
a value of 0.RNA purification, reverse transcription and quantitative
RT-PCR
Cecal samples were recovered from RNALater storage,
mixed with 1 mL TRI Reagent (MRC) and homogenized
with MagNALyzer (Roche). Fifty μL of bromoanisole was
added to the homogenate and after centrifugation for
15 min at 14 000 × g, the upper phase containing RNA
was collected and purified with RNeasy Mini Kit (Qiagen).
The concentration and purity of RNA was determined
spectrophotometrically (Nanodrop, Thermo Scientific).
One μg of RNA was immediately reverse transcribed into
cDNA using M-MLV reverse transcriptase (Invitrogen)
and oligo(dT) primers. Following the reverse transcrip-
tion, the cDNA was diluted 10× with sterile water and
stored at −20 °C prior to quantitative real-time PCR.
Mucosal immune response was characterized by real-
time PCR based on the expression of 36 genes identified
earlier [21,22]. Primers for the quantification of gene ex-
pression by real-time PCR are listed in Additional file 1.
Real-time PCR was performed in 3 μL volumes in 384-
well microplates using QuantiTect SYBR Green PCR
Master Mix (Qiagen) and Nanodrop II Stage pipetting
station (Innovadyne) for PCR mix dispensing. The amp-
lification and signal detection were performed using a
LightCycler II (Roche) with an initial denaturation at
95 °C for 15 min followed by 40 cycles of 95 °C for 20 s,
60 °C for 30 s and 72 °C for 30 s. Each sample was sub-
jected to real-time PCR in a duplicate and the mean Ct
value of duplicates was used for subsequent calculations.
The Ct values of the genes of interest were normalized
(ΔCt) to an average Ct value of three house-keeping genes,
i.e. glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
TATA box binding protein (TBP) and ubiquitin (UB). The
relative expression of each gene of interest was then calcu-
lated as 2−ΔCt.
Statistical analyses
Salmonella counts in HD11 cells, chicken tissues and
gene expression data from real-time PCR were analyzed
with ANOVA test followed by post hoc Tukey’s multiple
comparison test. P values ≤ 0.05 were considered as sig-
nificant. Heat maps were constructed in R using gplots
package with values standardized to row Z-scores. Experi-
mental groups in heat maps were reordered according to
column means.
Results
Infection of HD11 cells
First we tested whether the mutants and wild-type S. Enter-
itidis will differently interact with chicken macrophage-like
cell line in vitro being aware that the interaction with
HD11 cell line may not directly correlate with the inter-
action of the strain with chicken immune system in vivo.
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cellular counts than the wild-type S. Enteritidis or the SPI2
mutant 4 h post infection (Figure 1) but none of the com-
parisons reached statistical significance. Twenty four hours
post infection, intracellular counts of the wild-type strain
and the mutants decreased 3 to 5 fold.
When gene expression was determined, 14 genes
out of 36 tested were considered as not expressed in
HD11 cells as their relative expression was lower than
0.05, i.e. their expression did not reach 5% of the ex-
pression of the house-keeping genes (data not shown).
Genes such as TRAP6, AH221, STAT3, C3, ASL2,
STAT1, EPSTI1, IFIT5, RSFR, MPEG1, ITGLB2 and
HCLS1 were expressed in HD11 cells but though in-
ducible in the chicken cecum following S. Enteritidis
infection [22], these were not induced HD11 macro-
phages in response to S. Enteritidis infection. Instead,
RSFR, MPEG1, ITGLB2 and HCLS1 were suppressed
in HD11 cells 24 h after infection with wild type S.
Enteritidis. These genes were usually suppressed also
after infection with the SPI2, phoP and aroA mutants
but not with the SPI1 mutant (Figure 2).
The last group of genes included IL-1β, CXCLi2 (IL-8),
AVD, IRG1, iNOS, ExFABP, TGM4 and SAA whose
expression in HD11 cells increased after the infection
with S. Enteritidis (Figure 2). IL-1β, CXCLi2 (IL-8),
AVD, IRG1 and iNOS were induced by all the strains
and at both time points. Significant induction was less
frequent for ExFABP, TGM4 and SAA due to their
lower induction rate in comparison to IL-1β, CXCLi2
(IL-8), AVD, IRG1 and iNOS. However, the only strain
which never significantly induced ExFABP, TGM4 and
SAA in HD11 macrophage cell line was the SPI1 mu-
tant (Figure 2).Figure 1 Invasion and intracellular survival of the wild-type
S. Enteritidis and its mutants in HD11 cells. HD11 cells were
inoculated with approx. 105 CFU S. Enteritidis wild-type or the SPI1,
SPI2, aroA or phoP mutant (MOI = 1). Four and 24 h post infection,
intracellular bacterial counts were determined. Bars represent
mean and SD.Chicken response to inoculation with SPI1, SPI2, phoP and
aroA mutants of S. Enteritidis
As there were differences in the gene expression response
of HD11 macrophages to the infection with different mu-
tants, in the next experiment we tested whether chickens
would also recognize and respond differently to inocula-
tion with 4 different mutants and wild-type S. Enteritidis.
Four days after the inoculation, SPI1, SPI2, phoP and aroA
mutants colonized the cecum similarly as wild-type S.
Enteritidis and Salmonella counts in the cecum in all
inoculated groups were around 108 CFU/g (Figure 3).
However, systemic spread of all 4 mutants was limited as
their counts in the liver were significantly lower than that
of the wild-type strain (Figure 3).
Although S. Enteritidis counts in the cecum and liver
of the chickens inoculated with different mutants did
not indicate any difference in their residual virulence,
differences were observed in the gene expression in the
cecum. Except for MUC2L, IFIT5, LYG2, Ig λ light
chain, EPSTI1 and STAT1, expression of the remaining
genes was always numerically the highest in chickens in-
fected with wild-type S. Enteritidis (Figure 4). Expression
of MUC2L, IFIT5, LYG2, Ig λ light chain, EPSTI1 and
STAT1 was the highest in chickens inoculated with
either aroA or SPI2 mutant. In addition, SPI2 and aroA
mutants induced 18 and 27 genes of the 36 tested in in-
oculated chickens, respectively. On the other hand, not a
single gene out of those tested was significantly upregu-
lated after inoculation of the chickens with the SPI1 and
phoP mutants and the chickens inoculated with these
mutants clustered with the non-inoculated control group
(Figure 4). SPI1 and phoP mutants therefore did not stimu-
late an inflammatory response in inoculated chickens, SPI2
and aroA mutants stimulated moderate response and the
highest response was induced by the wild-type S.
Enteritidis.
Responsiveness of chickens of different ages to S.
Enteritidis infection
In the next experiment we determined resistance of dif-
ferently aged chickens to S. Enteritidis infection. Sal-
monella counts in the liver of chickens infected on day 1
were significantly higher than in chickens infected on
day 22 (Figure 5). On the other hand, differences in
counts of S. Enteritidis in the liver and cecum of chickens
infected on day 22 and 43 did not reach statistical signifi-
cance. When immune response was determined in the
cecum, the infection of newly hatched chickens with S.
Enteritidis led to a significantly increased expression of all
tested genes with matrix metalloproteinase 7 (MMP7) be-
ing upregulated nearly 1000×. An additional 21 genes were
induced more than 10× (Table 2). In 22-day-old chickens,
33 out of 36 tested genes were significantly upregulated.
Figure 2 Expression of genes in HD11 cells inoculated with wild-type S. Enteritidis and its mutants. The SPI1 mutant stimulated a different
response in HD11 cell line than the remaining strains or mutants. Panels in green, genes suppressed by S. Enteritidis infection 24 hours post infection
(hpi). Panels in red, genes induced by S. Enteritidis infection. Bars represent expression normalized to the average expression of 3 house-keeping genes.
* - statistically significant difference from the expression in the non-infected cells at P≤ 0.05.
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a high variation among individual chickens) and 8 other
genes (IL-22, ExFABP, IRG1, ES1, SAA, IL-17, MRP126
and AVD) were upregulated more than 10×. Infection of
43-day-old chickens led to a significant upregulation of 22
genes (Table 2). Since 22-day-old chickens were more re-
sponsive to S. Enteritidis infection than 43-day-old chick-
ens, 22-day-old chickens were selected for the comparison
of the immune response of naive and inoculated chickens
in the following experiment.
Response of chickens inoculated with SPI1, SPI2, phoP and
aroA mutants to challenge with wild-type S. Enteritidis
In the last experiment we addressed whether the inocu-
lation of newly hatched chickens with the mutants
would also result in a different interaction with the wild-
type S. Enteritidis after challenge. First we checked the
colonization of 22-day-old chickens by strains used for
initial inoculation. Except for 2 or 3 chickens inoculated
with the SPI2 and aroA mutant, respectively, all the
remaining chickens were free of S. Enteritidis in the
liver. However, all the chickens, irrespective of the strainused for the inoculation on day 1 of life, were still posi-
tive for S. Enteritidis in the cecum (Figure 3).
Four days after the challenge, S. Enteritidis counts in the
cecum of chickens originally inoculated with the SPI1, SPI2
and aroA mutant did not significantly differ from the
counts in chickens which were infected with wild-type S.
Enteritidis on day of hatch and re-infected on day 22, or
which were infected only on day 22 of life (Figure 3). Only
phoP-inoculated chickens were significantly protected
against wild-type S. Enteritidis challenge since S. Enteritidis
counts in the vaccinated birds were significantly lower than
in the non-vaccinated controls. Differences in Salmonella
counts in the liver were only of numerical value which did
not reach statistical significance, in this case including the
group inoculated with the phoP mutant (Figure 3).
However, there were clear differences when chicken
gene expression profiles were compared. During the
challenge experiment at 22 days of age, the responses
induced by challenge with S. Enteritidis in birds pre-
exposed to the mutants or the wild type S. Enteritidis
were different to those birds challenged for the first
time. Except for all immunoglobulin coding genes,
Figure 3 Salmonella counts in organs of chickens inoculated with wild-type S. Enteritidis and its mutants. Chickens were inoculated on
day of hatch with SPI1, SPI2, phoP and aroA S. Enteritidis mutants and challenged on day 22 of life. The data represent individual values and median
CFU/g tissue. Asterisks indicate statistically significant differences from chickens inoculated with wild-type S. Enteritidis at P≤ 0.05 (*). Non-vaccinated
chickens infected on day 22 of life are designated as “nv”. Some values from the chicken cecum are missing due to an overgrowth of plates with
non-Salmonella microbiota resistant to nalidixic acid.
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the naive chickens infected with the wild type S. Enteriti-
dis for the first time expressed the majority of the tested
genes at high levels (Figure 6).
The second group was formed by chickens inoculated
on day 1 with the wild-type S. Enteritidis and re-infected
on day 22. All immunoglobulin coding genes, MPEG1,
TGM4, MUC2L, ITGB2, HCLS1, RSFR, C3, STAT1,
IFNγ and ASL2 were expressed the most in chickens be-
longing to this group (Figure 6).
The third group was formed by chickens inoculated
with the SPI2 or aroA mutant and challenged with the
wild-type S. Enteritidis (Figure 6). Response of chickens
vaccinated with the SPI2 or aroA mutant resulted in a
significant upregulation of 13 or 11 genes, respectively,
with IRG1, ExFABP, MRP126 (calprotectin), HCLS1, IgY,
IgA and Ig λ chain being significantly induced in both
groups (Figure 6).The last group consisted of chickens inoculated with
the SPI1 or phoP mutant and challenged with the wild-
type S. Enteritidis. These were both protected against
the challenge as not a single gene was significantly in-
duced after the challenge with the wild-type and these
chickens therefore clustered with non-infected controls
(Figure 6).
Discussion
In this study we found out that 4 tested mutants and the
wild-type S. Enteritidis were differently recognized and
processed by HD11 macrophage cell line and the
chicken immune system in general. HD11 macrophages
responded to the infection with the wild type S. Enteriti-
dis and SPI2, phoP and aroA mutants by an increase in
transcription of inflammatory genes such as IL-1β,
CXCLi2 (IL-8), ExFABP, AVD, IRG1 or iNOS. Repeat-
edly lower induction of these genes was observed in
Figure 4 Gene expression in chickens inoculated with wild-type S. Enteritidis and its mutants. Chickens were infected on day of hatch with
wild-type S. Enteritidis or SPI1, SPI2, phoP and aroA mutants, and euthanized 4 days later. Heat map shows average gene expression in groups of chickens.
Asterisks indicate statistically significant difference from the expression in the non-infected chickens at P≤ 0.05 (*), P≤ 0.01 (**), or P≤ 0.001 (***). Maximal
fold increase is shown to highlight the differences between the green and red color range for each of the genes. Minimal and maximal expression levels
are shown to remind that higher fold inductions are more frequent for genes with a lower basal expression.
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contradiction with the high inflammatory signaling of
porcine alveolar macrophages infected with the SPI1
mutant when compared with those infected with the
wild-type S. Enteritidis [25]. The likely explanation is the
different origin of the cell, primary porcine macrophages
and cell line in the case of HD11 chicken macrophages.
Behavior of HD11 macrophages was therefore dependent
on SPI1-dependent invasion with the invasion deficient
SPI1 mutant inducing the lowest inflammatory signaling.
Inoculation of newly hatched chickens with the SPI1
and also phoP mutant did not result in inflammation,
which corresponds with our previous observations on
vaccination with the SPI1 mutant [13]. Although the
chickens at the time of challenge were still positive for
the mutants used for inoculation on day 1 of life, we be-
lieve that this did not negatively affect results as it hasbeen shown that inflammatory response decreases in
chickens between the 2nd and 3rd week of life [22]. The
fact that we did not record extensive differences in
bacterial counts after challenge in different groups was
likely due to an early time point for analysis, i.e. 4 days
post infection. Moreover, since we did not discriminate
between the counts of vaccine and challenge strains, es-
pecially the counts in the cecum have to be taken with a
certain care since these could be a mixture of vaccine
and challenge strains. Despite this, immune responses to
challenge were quite different across all groups. Chickens
inoculated with the SPI1 or phoP mutant were resistant to
the wild-type S. Enteritidis challenge as this did not
trigger any inflammatory response at 4 days post chal-
lenge (Figure 6). Antibody production was stimulated
in the chickens inoculated with SPI2 and aroA mutants
and challenged with the wild-type, similarly, though to
Figure 5 Salmonella counts in organs of chickens infected with wild-type S. Enteritidis at different ages. Chickens were infected with
wild-type S. Enteritidis on day 1, 22 or 43 of life and euthanized 4 days later. The data represent individual values and median CFU/g tissue.
Asterisks indicate statistically significant difference from Salmonella counts in 5-day-old chickens 4 days post infection at P≤ 0.05 (*).
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wild-type S. Enteritidis. Recently we documented that
vaccination with the SPI2 mutant resulted in a higher
antibody production determined by ELISA than vaccin-
ation with the SPI1 mutant [13]. However, it should be
reminded that in all the experiments we used a single
time point for analysis of immune response. We there-
fore cannot exclude a similar response to vaccination
or challenge with different dynamics, i.e. we cannot
exclude an earlier or delayed response of the chickens
to the vaccination or challenge with different mutants
or wild type S. Enteritidis.
The comparative approach used in this study also
allowed us to address the function of individual genes in-
volved in the chicken response to S. Enteritidis infection.
Cluster I in Figure 6 represents genes of early response
that are highly inducible in response to S. Enteritidis espe-
cially in non-protected chickens. These genes include ES1,
IFIT5, EPSTI1, LYG2 and MMP7 expressed in cells of
non-leukocyte origin [26-31], IRG1, AVD, ExFABP, SAA,
IL-1β and TRAP6 expressed in macrophages and hetero-
phils [21,32], CXCLi2 (IL-8) produced by both intestinal
epithelial cells and phagocytes [33-35], and IL-17 and IL-
22 expressed in T-lymphocytes [33]. Most of these genes
were reported to be induced also after infections with
other pathogens [36-39]. These genes can be therefore
understood as being involved in the innate immune re-
sponse and can be used as sensitive markers for gut in-
flammation in chickens.
The second cluster of genes was formed by IFNγ and
AH221, iNOS, ASL2, STAT1 and TAP1 (Figure 6). These
genes were expressed to a similar extent in chickens in-
fected twice with the wild-type S. Enteritidis and inchickens infected with S. Enteritidis for the first time at
the age of 22 days. However, significant induction was re-
corded only in re-infected chickens. Except for IFNγ pro-
duced by T-lymphocytes and NK cells, all these genes are
characteristic of macrophages [21], and represent com-
mon markers of Th1 immune response characterized by
NO radical production and arginine/ornithine recycling
by ASL2 [40].
Group III included all 4 immunoglobulin encoding
genes, MUC2L, ITGB2, HCLS1, RSFR, TGM4, MPEG1
and C3 (Figure 4). Similarly to immunoglobulins,
TGM4, ITGB2 (CD18) and HCLS1 are expressed by B-
lymphocytes, with ITGB2 and HCLS1 being also
expressed by other hematopoietic cells [21,41-43]. All
these genes were significantly induced in 22-day-old
chickens only after repeated Salmonella infection. Some
of these genes were induced also in the chickens inocu-
lated with the aroA and SPI2 mutants. These genes are
associated with B-lymphocyte differentiation and conse-
quently with specific immune response and antibody
production [44,45].
However, the results following the inoculation with
phoP and SPI1 mutants were the most surprising. One
would expect that if these mutants did not induce at
least moderate inflammation as did the SPI2 or aroA
mutant, specific immunity could not develop and chal-
lenged chickens should respond as the naive controls,
which was not the case. The reason for the different
development of specific immunity is not known. How-
ever, it is possible that due to a decreased ability to in-
vade intestinal epithelial cells, S. Enteritidis SPI1 mutant
should be present mainly in professional phagocytes and
antigen presenting cells without being able to cause their
Table 2 Age-dependent responsiveness of chickens to S. Enteritidis infection
Function/gene Description Fold increase in chickens*
day 1 day 21 day 42
Cytokines
IL-1β interleukin 1 21.1 ± 14.4$ 2.6 ± 1.4 4.2 ± 3.8
CXCLi2 (IL-8 L2) interleukin 8 5.9 ± 1.6 9.4 ± 4.9 7.1 ± 4.5
IL-17 interleukin 17 2.9 ± 1.5 14.4 ± 8.5 12.4 ± 10.3
IL-22 interleukin 22 50.1 ± 30.4 44.4 ± 27.9 12.3 ± 9.8
IFNγ interferon gamma 20.1 ± 12.1 6.9 ± 3.6 2.7 ± 1.7
AH221 chemokine AH221 (CCLi9) 36.8 ± 7.4 3.6 ± 2.0 4.1 ± 2.5
Immunoglobulins
IgM immunoglobulin M heavy chain, C-region 25.8 ± 10.0 2.9 ± 1.0 1.8 ± 0.9
IgY imunoglobulin Y heavy chain, C-region 44.9 ± 18.2 3.6 ± 1.5 0.9 ± 0.3
IgA imunoglobulin A heavy chain, C-region 19.3 ± 11.8 2.9 ± 1.3 1.5 ± 0.4
Ig λ immunoglobulin lambda light chain, C-region 25.1 ± 8.8 3.1 ± 1.6 0.6 ± 0.2
Other immune response proteins
IRG1 immune responsive gene 1 186.2 ± 42.9 22.5 ± 11.5 25.6 ± 20.0
iNOS inducible NO synthase 58.1 ± 18.1 5.8 ± 3.9 22.0 ± 19.7
MRP126 MRP-126 (S100A9, calprotectin, calgranulin B) 33.0 ± 13.6 10.1 ± 4.2 9.3 ± 11.3
PTGDS prostaglandin D2 synthase 21 kDa (brain) 11.9 ± 4.0 2.2 ± 1.0 7.4 ± 5.5
C3 complement 3 11.4 ± 2.2 3.5 ± 1.1 2.5 ± 1.0
IFIT5 interferon-induced protein with tetratricopeptide repeats 5 3.6 ± 0.9 4.5 ± 2.5 8.8 ± 5.1
ASL2 argininosuccinate lyase 4.5 ± 1.0 2.6 ± 1.0 2.6 ± 1.2
MPEG1 macrophage-expressed gene 1 protein-like 4.0 ± 0.6 1.3 ± 0.2 2.6 ± 0.9
ITGB2 integrin beta-2 precursor 6.6 ± 1.1 1.6 ± 0.4 2.3 ± 1.0
TAP1 transporter 1, ATP-binding cassette, sub-family B 5.0 ± 1.4 2.4 ± 0.9 3.4 ± 1.4
STAT1 signal transducer and activator of transcription 1 4.1 ± 0.6 1.8 ± 0.4 3.0 ± 1.2
STAT3 signal transducer and activator of transcription 3 1.9 ± 0.2 1.2 ± 0.2 2.1 ± 0.6
Acute phase response
SAA serum amyloid A 150.7 ± 61.1 15.4 ± 9.7 22.5 ± 22.8
AVD avidin 27.0 ± 8.4 10.1 ± 5.4 8.9 ± 5.9
HPX hemopexin 7.0 ± 2.7 3.0 ± 2.1 3.5 ± 1.5
Mucosal defense
MMP7 matrix metallopeptidase 7 (matrilysin, uterine) 939.1 ± 287.1 138.8 ± 149.1 12.6 ± 11.4
ExFABP extracellular fatty-acid binding protein (P20K, LCN8) 177.0 ± 57.4 27.7 ± 14.5 11.6 ± 10.1
TRAP6 trappin-6 64.8 ± 22.5 3.8 ± 2.1 10.6 ± 10.0
LYG2 lysozyme g-like 2 32.9 ± 6.3 4.5 ± 3.1 15.8 ± 8.6
MUC2L mucin-2-like 3.5 ± 1.3 8.5 ± 4.9 2.2 ± 1.5
Hematopoiesis, angiogenesis
SERPINB10 serpin peptidase inhibitor, clade B (ovalbumin), member 10 18.0 ± 9.8 3.8 ± 1.5 8.8 ± 6.3
HCLS1 hematopoietic lineage cell-specific protein 1 7.8 ± 1.5 1.8 ± 0.6 1.9 ± 0.8
RSFR leucocyte ribonuclease A-2, angiogenin 7.5 ± 1.7 1.7 ± 0.5 1.9 ± 0.9
Other
TGM4 glutamine γ-glutamyltransferase 4 37.5 ± 12.0 2.3 ± 1.1 9.9 ± 13.9
ES1 ES1 protein homolog 21.4 ± 8.9 22.4 ± 17.8 17.5 ± 13.0
EPSTI1 epithelial stromal interaction 1 (breast) 3.6 ± 0.9 3.1 ± 0.9 1.7 ± 0.8
*Chickens were infected on day 1, 21 or 42 with S. Enteritidis and euthanized 4 days after the infection. The table presents a fold increase in gene expression after
the infection with 95% confidence interval.
$Values in bold indicate significant difference from the expression in age-matched non-infected control chickens.
Elsheimer-Matulova et al. Veterinary Research  (2015) 46:96 Page 9 of 12
Figure 6 Gene expression in inoculated chickens 4 days after challenge with wild-type S. Enteritidis. Chickens were inoculated on day of
hatch with SPI1, SPI2, phoP and aroA S. Enteritidis mutants, challenged on day 22 of life and euthanized 4 days later. Heat map shows average
gene expression in groups of chickens. Group I of genes represents genes belonging mainly to innate immune response, group II genes
belonging to Th1 cell mediated immune response and group III is mainly associated with B-lymphocyte development and antibody production.
Asterisks indicate statistically significant difference from the non-infected chickens at P ≤ 0.05 (*), P ≤ 0.01 (**) or P ≤ 0.001 (***). Maximal fold
increase is shown to highlight the differences between the green and red color range for each of the gene. Minimal and maximal expression
levels are shown to remind that higher fold inductions are more frequent for genes with a lower basal expression.
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creased intracellular replication without causing cell
death [18]. It is therefore tempting to speculate that if
the whole tissue is inflamed, immune response is polar-
ized towards Th2 response and antibody production. On
the other hand, if cells present in the cecal tissue are not
stimulated for inflammatory signaling, the immune sys-
tem is then polarized towards cell-mediated response.
Although the above mentioned hypothesis will have to
be proven experimentally, it can be concluded that phoP,
aroA, SPI1 and SPI2 mutants were recognized and proc-
essed differently by the chicken immune system which
might help in developing vaccines against either sys-
temic or gut infection.Additional file
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